| Pharmaceutical Information |
| Drug Name |
Amlexanox |
| Drug ID |
BADD_D00120 |
| Description |
Amlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population. |
| Indications and Usage |
Used as a paste in the mouth to treat aphthous ulcers (canker sores). |
| Marketing Status |
approved; investigational; withdrawn |
| ATC Code |
A01AD07; R03DX01 |
| DrugBank ID |
DB01025
|
| KEGG ID |
D01828
|
| MeSH ID |
C045742
|
| PubChem ID |
2161
|
| TTD Drug ID |
D0G5UB
|
| NDC Product Code |
71052-005; 73309-350 |
| UNII |
BRL1C2459K
|
| Synonyms |
amlexanox | 2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid | amoxanox | Aphthasol | CHX 3673 | AA 673 | AA-673 |
|
| Chemical Information |
| Molecular Formula |
C16H14N2O4 |
| CAS Registry Number |
68302-57-8 |
| SMILES |
CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
